| Bloomsburg Care Center And Rehabilitation Center | |
| 211 East First Street, Bloomsburg, Pennsylvania 17815 | |
| (570) 784-5930 | |
| Name | Bloomsburg Care Center And Rehabilitation Center |
|---|---|
| Location | 211 East First Street, Bloomsburg, Pennsylvania |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 149 |
| Occupancy Rate | 68.05% |
| Medicare ID (CCN) | 396065 |
| Legal Business Name | Bloomsburg Care And Rehabilitation Center, Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1942709969 |
| Organization Name | BLOOMSBURG CARE AND REHABILITATION CENTER, LLC |
| Doing Business As | BLOOMSBURG CARE AND REHABILITATION CENTER |
| Address | 211 E 1st St, Bloomsburg, PA 17815 |
| Phone Number | 570-784-5930 |
News Archive
Scientists in Sydney, Australia, have discovered that obesity and type 2 diabetes in pregnancy can program children to develop metabolic problems later in life. The good news is, this legacy is not set in stone-if children of obese mothers are careful about what they eat, it can be overturned.
According to Queensland Premier Anna Bligh, new developments are on the horizon only if her Government continues with the sell off of $15 billion of public assets. She revealed this in her annual State of the State address at the mid point of her term in Government yesterday while reviewing the past 18 months and forecasting the next stage of the state's development.
Embryonic stem cells may one day provide a means to treat disease, but according to two new reports, they are already revealing remarkable insights into the mysteries of human biology. How humans manage to develop from a single fertilized egg into the trillions of cells that make up a mature adult remains a poorly understood process. Now, using both human and mouse embryonic stem cells, researchers have mapped how a key developmental ingredient controls the genome.
Earlier today, at the American Psychiatric Association Annual Meeting in Philadelphia, Dr. Ian Cook, Principal Investigator and Professor of Psychiatry at UCLA, and a Senior Medical Advisor to NeuroSigma, Inc., presented the results of a Phase Ib open-label clinical trial that studied the effects of eTNS™ on depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy. Results from the 17-question Hamilton Depression Rating Scale (HDRS-17), a clinician-rated scale, showed a 50.0% reduction in depression and the Beck Depression Inventory (BDI), a self-reported scale, showed a 58.0% reduction in scores. Both scales achieved statistical significance. In the trial, subjects placed stimulating eTNS™ electrodes on their foreheads for 8 hours each night and their depression was measured every two weeks using recognized standard tests. eTNS was well tolerated and no serious adverse events occurred during the 8-week treatment period.
› Verified 7 days ago
| NPI Number | 1962404251 |
| Organization Name | GEISINGER BLOOMSBURG HEALTH CARE CENTER |
| Address | 211 E 1st St, Bloomsburg, PA 17815 |
| Phone Number | 570-784-5930 |
News Archive
Scientists in Sydney, Australia, have discovered that obesity and type 2 diabetes in pregnancy can program children to develop metabolic problems later in life. The good news is, this legacy is not set in stone-if children of obese mothers are careful about what they eat, it can be overturned.
According to Queensland Premier Anna Bligh, new developments are on the horizon only if her Government continues with the sell off of $15 billion of public assets. She revealed this in her annual State of the State address at the mid point of her term in Government yesterday while reviewing the past 18 months and forecasting the next stage of the state's development.
Embryonic stem cells may one day provide a means to treat disease, but according to two new reports, they are already revealing remarkable insights into the mysteries of human biology. How humans manage to develop from a single fertilized egg into the trillions of cells that make up a mature adult remains a poorly understood process. Now, using both human and mouse embryonic stem cells, researchers have mapped how a key developmental ingredient controls the genome.
Earlier today, at the American Psychiatric Association Annual Meeting in Philadelphia, Dr. Ian Cook, Principal Investigator and Professor of Psychiatry at UCLA, and a Senior Medical Advisor to NeuroSigma, Inc., presented the results of a Phase Ib open-label clinical trial that studied the effects of eTNS™ on depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy. Results from the 17-question Hamilton Depression Rating Scale (HDRS-17), a clinician-rated scale, showed a 50.0% reduction in depression and the Beck Depression Inventory (BDI), a self-reported scale, showed a 58.0% reduction in scores. Both scales achieved statistical significance. In the trial, subjects placed stimulating eTNS™ electrodes on their foreheads for 8 hours each night and their depression was measured every two weeks using recognized standard tests. eTNS was well tolerated and no serious adverse events occurred during the 8-week treatment period.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Scientists in Sydney, Australia, have discovered that obesity and type 2 diabetes in pregnancy can program children to develop metabolic problems later in life. The good news is, this legacy is not set in stone-if children of obese mothers are careful about what they eat, it can be overturned.
According to Queensland Premier Anna Bligh, new developments are on the horizon only if her Government continues with the sell off of $15 billion of public assets. She revealed this in her annual State of the State address at the mid point of her term in Government yesterday while reviewing the past 18 months and forecasting the next stage of the state's development.
Embryonic stem cells may one day provide a means to treat disease, but according to two new reports, they are already revealing remarkable insights into the mysteries of human biology. How humans manage to develop from a single fertilized egg into the trillions of cells that make up a mature adult remains a poorly understood process. Now, using both human and mouse embryonic stem cells, researchers have mapped how a key developmental ingredient controls the genome.
Earlier today, at the American Psychiatric Association Annual Meeting in Philadelphia, Dr. Ian Cook, Principal Investigator and Professor of Psychiatry at UCLA, and a Senior Medical Advisor to NeuroSigma, Inc., presented the results of a Phase Ib open-label clinical trial that studied the effects of eTNS™ on depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy. Results from the 17-question Hamilton Depression Rating Scale (HDRS-17), a clinician-rated scale, showed a 50.0% reduction in depression and the Beck Depression Inventory (BDI), a self-reported scale, showed a 58.0% reduction in scores. Both scales achieved statistical significance. In the trial, subjects placed stimulating eTNS™ electrodes on their foreheads for 8 hours each night and their depression was measured every two weeks using recognized standard tests. eTNS was well tolerated and no serious adverse events occurred during the 8-week treatment period.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 19.32 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 12.04 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 43.33 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.55 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.6 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 4.49 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 6.04 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 85.44 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 11.37 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 71.95 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.15 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 36.84 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 14.25 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 8.53 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 93.81 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 75.2 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 71.7 | 82.93 |
News Archive
Scientists in Sydney, Australia, have discovered that obesity and type 2 diabetes in pregnancy can program children to develop metabolic problems later in life. The good news is, this legacy is not set in stone-if children of obese mothers are careful about what they eat, it can be overturned.
According to Queensland Premier Anna Bligh, new developments are on the horizon only if her Government continues with the sell off of $15 billion of public assets. She revealed this in her annual State of the State address at the mid point of her term in Government yesterday while reviewing the past 18 months and forecasting the next stage of the state's development.
Embryonic stem cells may one day provide a means to treat disease, but according to two new reports, they are already revealing remarkable insights into the mysteries of human biology. How humans manage to develop from a single fertilized egg into the trillions of cells that make up a mature adult remains a poorly understood process. Now, using both human and mouse embryonic stem cells, researchers have mapped how a key developmental ingredient controls the genome.
Earlier today, at the American Psychiatric Association Annual Meeting in Philadelphia, Dr. Ian Cook, Principal Investigator and Professor of Psychiatry at UCLA, and a Senior Medical Advisor to NeuroSigma, Inc., presented the results of a Phase Ib open-label clinical trial that studied the effects of eTNS™ on depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy. Results from the 17-question Hamilton Depression Rating Scale (HDRS-17), a clinician-rated scale, showed a 50.0% reduction in depression and the Beck Depression Inventory (BDI), a self-reported scale, showed a 58.0% reduction in scores. Both scales achieved statistical significance. In the trial, subjects placed stimulating eTNS™ electrodes on their foreheads for 8 hours each night and their depression was measured every two weeks using recognized standard tests. eTNS was well tolerated and no serious adverse events occurred during the 8-week treatment period.
› Verified 7 days ago
Sunset Ridge Healthcare And Rehabilitation Center Location: 3298 Ridge Road, Bloomsburg, Pennsylvania 17815 Phone: (570) 784-6688 | |
Bloomsburg Care Center And Rehabilitation Center Location: 211 East First Street, Bloomsburg, Pennsylvania 17815 Phone: (570) 784-5930 |